USMD HOSPITAL OF ARLINGTON — History
CCN 450872 | 3-year financial timeline | COVID resilience: 31/100
🛡️ Public data only — no PHI permitted on this instance.
$55M
Latest Revenue (FY2022)
-1.5%
Revenue CAGR (3yr)
-22.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $56M | $64M | $55M | -14.6% | -1.5% |
| Operating Expenses | $60M | $68M | $67M | -1.9% | +6.2% |
| Operating Margin | -5.6% | -6.9% | -22.8% | -232.2% | +0.0% |
| Net Income | $-3M | $-4M | $-12M | -183.6% | +0.0% |
| Licensed Beds | 34 | 34 | 34 | +0.0% | +0.0% |
| Total Patient Days | 2,690 | 3,393 | 1,874 | -44.8% | -16.5% |
| Medicare Day % | 24% | 15% | 15% | +1.1% | -21.5% |
| Medicaid Day % | nan% | 0% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 31/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -3.0% ($56M → $55M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-1.5%
This Hospital
+7.6%
State Avg
Latest Margin
-22.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $54M | -31.4% |
| FY2024 (proj) | $53M | -40.0% |
| FY2025 (proj) | $52M | -48.6% |